Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease

被引:0
作者
Borchert, GH
Yu, H
Tomlinson, G
Giai, M
Roagna, R
Ponzone, R
Sgro, L
Diamandis, EP
机构
[1] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
[2] Louisiana State Univ, Med Ctr, Sch Med, Sect Hematol Oncol,Dept Med, Shreveport, LA 71130 USA
[3] Univ Toronto, Dept Prevent Med & Biostat, Toronto, ON, Canada
[4] Univ Turin, Inst Obstet & Gynecol, Dept Gynecol Oncol, I-10124 Turin, Italy
[5] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
关键词
prostate specific antigen; breast cyst fluid; fibrocystic breast diseases; molecular forms of PSA; free/bound PSA ratio; electrolyte ratio;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We have analyzed matched serum and breast cyst fluid samples for total PSA from 148 patients with fibrocystic breast disease. We have also determined the molecular forms of PSA (free PSA and PSA bound to al-antichymotrypsin) in 78 breast cyst fluid samples. We found that total PSA can be detected in all cyst fluids and in about 75% of female sera. The median total PSA concentration in breast cyst fluid (bcf) is about 30 times higher than the median in the corresponding sera. Breast cyst fluid and serum PSA are not correlated with each other. Total serum PSA is inversely associated with patient age but the inverse association between bcf PSA and age is weak. Lower total PSA in bcf was seen in women who breast feed, and higher bcf PSA is associated with multiple cysts. Type I cysts (with a high K+/Na+ ratio) tend to have higher total PSA than Type II cysts. All but three of the fractionated cyst fluids (75/78; 96%) had free PSA as the predominant molecular form. The most consistent finding of our study was the positive association between the cyst fluid K+/Na+ ratio and the free to bound PSA ratio. This association was confirmed by Spearman correlation as well as by Wilcoxon and chi-square analysis. Secretory/apocrine cysts (Type I) tend to have more total PSA and proportionally more free PSA than transudative/flattened cysts (Type II). J. Clin. Lab. Anal. 13:75-81, 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 50 条
  • [21] DETECTION OF PROSTATE-SPECIFIC ANTIGEN IMMUNOREACTIVITY IN BREAST TURNERS
    DIAMANDIS, EP
    YU, H
    SUTHERLAND, DJA
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (03) : 301 - 310
  • [22] Prostate-specific antigen value as a marker in breast cancer
    Narita, D
    Cimpean, AM
    Anghel, A
    Raica, M
    NEOPLASMA, 2006, 53 (02) : 161 - 167
  • [23] Immunohistochemical labelling for prostate-specific antigen in breast carcinomas
    Alanen, KA
    Kuopio, T
    Collan, YU
    Kronqvist, P
    Juntti, L
    Nevalainen, TJ
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 56 (02) : 169 - 176
  • [24] Comparative study of assays for prostate-specific antigen molecular forms
    Kuriyama, M
    Uno, H
    Ueno, K
    Hamamoto, Y
    Vihn, PQ
    Ban, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (06) : 303 - 307
  • [25] Prostate-specific antigen in nipple aspiration fluid: Menstrual cycle variability and correlation with serum prostate-specific antigen
    Mitchell, G
    Sibley, PEC
    Wilson, APM
    Sauter, E
    A'Hern, R
    Eeles, RA
    TUMOR BIOLOGY, 2002, 23 (05) : 287 - 297
  • [26] Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 μg/L:: Are they useful tools for early detection and screening of prostate cancer?
    Jung, K
    Stephan, C
    Elgeti, U
    Lein, M
    Brux, B
    Kristiansen, G
    Rudolph, B
    Hauptmann, S
    Schnorr, D
    Loening, SA
    Sinha, P
    INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (05) : 759 - 765
  • [27] Ratio of prostate specific antigen-minor molecular forms-to-total prostate specific antigen is constant regardless of the pathological condition of the prostate
    Kobayashi, T
    Kamato, T
    Isogawa, Y
    Kinoshita, H
    Terai, A
    Habuchi, T
    Ogawa, O
    JOURNAL OF UROLOGY, 2003, 169 (01) : 121 - 124
  • [28] Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry
    Vegvari, Akos
    Rezeli, Melinda
    Sihlbom, Carina
    Hakkinen, Jari
    Carlsohn, Elisabet
    Malm, Johan
    Lilja, Hans
    Laurell, Thomas
    Marko-Varga, Gyorgy
    CLINICAL BIOCHEMISTRY, 2012, 45 (4-5) : 331 - 338
  • [29] Breast metastasis from prostate cancer and interpretation of immunoreactivity to prostate-specific antigen
    Cheng, CW
    Chan, LW
    Ng, CF
    Chan, CK
    Tse, MKG
    Lai, MMF
    INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (04) : 463 - 465
  • [30] The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast
    Margot H. Black
    Eleftherios P. Diamandis
    Breast Cancer Research and Treatment, 2000, 59 : 1 - 14